Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Baroni, IT
Domenico Baroni, Torino (to) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110190445 | INHIBITION OF HRP-3 USING MODIFIED OLIGONUCLEOTIDES - The present invention refers to agents for modulating the activity of proteins having a PWWP domain. | 08-04-2011 |
Guido Baroni, Monza (milano) IT
| Patent application number | Description | Published |
|---|---|---|
| 20080300681 | BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed. | 12-04-2008 |
| 20090181104 | BREAST RECONSTRUCTION OR AUGMENTATION USING COMPUTER-MODELED DEPOSITION OF PROCESSED ADIPOSE TISSUE - A tissue transfer method for reconstruction and augmentation of soft tissue. The method includes harvesting adipose tissue from a patient. The harvested tissue is processed via centrifugation to isolate a purified subset of the adipose tissue including separating and removing a substantial amount of triglycerides from the harvested adipose tissue. The centrifugation may be performed to cause separation of water from the purified adipose tissue and to cause separation of oil from mature adipocytes. Specifically, the spin rates may be selected to be high enough to cause lesions in the mature adipocytes that results in the release of the oil. The method continues with implanting the purified adipose tissue into the patient at a breast or other area identified for reconstruction or augmentation. The implanting is performed based on an injection pathway model that defines injection point locations and a number of injection pathway directions from each point. | 07-16-2009 |
Guido Baroni, Monza IT
| Patent application number | Description | Published |
|---|---|---|
| 20100160948 | BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed. | 06-24-2010 |
| 20100161052 | BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed. | 06-24-2010 |
| 20100168780 | BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed. | 07-01-2010 |
Marco Baroni, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100210662 | INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The present invention relates to 3-disubstituted indol-2-one derivatives, to their preparation and to their therapeutic application. | 08-19-2010 |
| 20110118280 | INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The present invention relates to 3-disubstituted indol-2-one derivatives, to their preparation and to their therapeutic application. | 05-19-2011 |
| 20110144116 | DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS - The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I): | 06-16-2011 |
Marco Baroni, Vanzago-Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110144120 | PHENYL-ALKYL PIPERAZINES HAVING TNF-MODULATING ACTIVITY, PREPARATION METHOD, AND THERAPEUTIC USE THEREOF - The present invention relates to phenyl-alkyl piperazines of formula (I): | 06-16-2011 |
| 20110144122 | DERIVATIVES OF 2-OXOALKYL-1-PIPERAZIN-2-ONE, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME - The present invention relates to derivatives of 4-{2-[phenyl-3,6-dihydropyridin-1-yl]-2-oxoalkyl}-1-piperazin-2-one and 4-{2-[phenyl-2,5-dihydropyrrol-1-yl]-2-oxoalkyl}-1-piperazin-2-one having general formula (I): | 06-16-2011 |
Marco Baroni, Barbasso Di Roncoferraro (mantova) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110041456 | ROTARY CONVEYOR COMPRISING A GRIPPER MECHANISM - The components of a rotary conveyor ( | 02-24-2011 |
| 20110120055 | ENCLOSING STRUCTURE FOR CONTAINER PACKAGING MACHINES AND/OR MACHINE UNITS, IN PARTICULAR CAPPING MACHINES - A packaging machine or machine unit, as used in particular for capping containers ( | 05-26-2011 |
Massimo Baroni, Castellarano(re) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110077829 | CONTROL OF A CONTINUOUSLY VARIABLE TRANSMISSION - A method is described for operating a vehicle fitted with a continuously variable transmission (CVT) and having a lever for varying the transmission ratio of the CVT to permit the vehicle operator to vary the vehicle wheel speed. In the invention, the transmission ratio of the CVT is limited to a value dependent upon at least one of the prevailing engine speed and the rate of change of the engine speed. | 03-31-2011 |
Massimo Baroni, Castellarano (re) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100216595 | System and Method for Controlling the Torque Transferable by a Mechanical Drive Employing an Oil-Bath Clutch - A system and method for controlling the torque transferable by a mechanical drive between an engine and a shaft of a vehicle includes a first actuator which acts on a variable-speed drive, a second actuator which acts on a clutch to determine the degree of engagement/release of the clutch; and a measuring device for measuring the torque to or from the variable-speed drive. The first and second actuators and the measuring device are controlled by an electronic central control unit to protect the variable-speed drive and/or the clutch from mechanical overloading of the mechanical drive. | 08-26-2010 |
Maurizio Baroni, Chiari IT
| Patent application number | Description | Published |
|---|---|---|
| 20080258419 | Suspension for a wheel of a motor-vehicle, in particular a bus - In a suspension for a wheel of a motor-vehicle, supporting, through a corresponding articulated spindle, V-shape arms, receiving a spring forming resilient cushioning element thereon the motor vehicle body bears, the resilient cushioning element comprises a base bearing on parallel guides of the V-shape arms, thereby forming a bearing surface, the central guide including a hole for receiving a throughgoing clamping screw for clamping the resilient cushioning element at a target position. | 10-23-2008 |
Paolo Baroni, Gattinara IT
| Patent application number | Description | Published |
|---|---|---|
| 20110110388 | METHOD AND APPARATUS FOR REDUCING THE AMPLITUDE MODULATION OF OPTICAL SIGNALS IN EXTERNAL CAVITY LASERS - The present invention concerns a laser apparatus ( | 05-12-2011 |
Sergio Baroni, Villa D'Adda (bg) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110288058 | Methods for Preventing or Reducing Colon Carcinogenesis - The present invention is directed in part to methods of preventing or reducing colon carcinogenesis comprising administering to a patient at risk of colorectal cancer, a pharmaceutical preparation comprising disclosed chemopreventive. In another aspect, the invention is directed to methods attenuation of oxygen free radicals comprising administrating to a patient in need thereof an antioxidant effective amount of a compound represented by formula I, IIa or IIb as disclosed herein. | 11-24-2011 |
| 20110288177 | Methods for Preventing or Reducing Colon Carcinogenesis - The present invention is directed in part to methods of preventing or reducing colon carcinogenesis comprising administering to a patient at risk of colorectal cancer, a pharmaceutical preparation comprising a chemopreventive agent disclosed herein. | 11-24-2011 |
Sergio Baroni, Villa D'Adda IT
| Patent application number | Description | Published |
|---|---|---|
| 20090048343 | Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R | 02-19-2009 |
| 20090118357 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field - Therefore the present invention relates specifically to the compounds of general formula (I), in which R | 05-07-2009 |
| 20110039808 | Multitarget Compounds Active at a PPAR and Cannabinoid Receptor - There is a need for pharmaceutical compounds which have activity at, at least one of a PPAR and a cannabinoid receptor. Thus there are provided such compounds, wherein the compound comprises: a PPAR pharmacophore and a cannabinoid pharmacophore linked together by a moiety comprising a fused bicyclic ring comprising a five membered ring fused with a six membered ring or a six membered ring fused with a six membered ring; wherein the cannabinoid pharmacophore comprises the fused bicyclic ring; and the PPAR pharmacophore comprises a salicylic acid, alkoxybenzylacetic acid or a alkoxyphenylacetic acid functionality; and wherein the PPAR pharmacophore is linked to the bicyclic ring of the cannabinoid pharmacophore through a linker comprising an amine or an amide functional group. | 02-17-2011 |
| 20110218245 | USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The object of the present invention is the use of compounds designed to inhibit the activity of the enzyme 5α-reductase. This is a novel use of compounds of general formula (I): | 09-08-2011 |
Sergio Baroni, Villa D' Adda IT
| Patent application number | Description | Published |
|---|---|---|
| 20090258837 | Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation - The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int) | 10-15-2009 |
| 20100323980 | Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation - The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int) | 12-23-2010 |
| 20110218164 | THERAPEUTIC, DIETARY OR COSMETIC USE OF COMPOUNDS WITH SPECIFIC ANTI-APOPTOTIC ACTIVITY TOWARD CASPASE-3, AND COMPOSITIONS CONTAINING THESE COMPOUNDS - This invention regards the use of zeaxanthin and/or rutin, as such or further combined with spermidine, as the active principle in a pharmaceutical, dietary, or cosmetic composition, acting to inhibit caspase-3 and therefore to control apoptosis by preventing programmed cell death. | 09-08-2011 |
| 20110224298 | DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The present invention relates to a novel use of compounds having the general formula (I): | 09-15-2011 |
Sergio Baroni, Bergamo IT
| Patent application number | Description | Published |
|---|---|---|
| 20100305077 | COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNO-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE - In one aspect, the present invention relates to amino-salicylic-aminophenylpropionic compounds for the use in the treatment of the inflammatory component of the celiac disease. These compounds act by blocking the cytokines released in the celiac disease and are specifically useful in the treatment of cases refractory to the diet, in dietary errors and in the reduction of the celiac disease remission time. | 12-02-2010 |
Sergio Baroni, Milan IT
| Patent application number | Description | Published |
|---|---|---|
| 20100034904 | COMPOSITION COMPRISONG RUTIN AND POLYUNSATURATED FATTY ACID HAVING AN INHIBITORY ACTIVITY ON 5-ALPH REDUCTASE - The present invention relates to the use of selected active principles of a natural origin in substitution of extract from Boehmeria Nipononivea for regulating the trophism of hair follicles and the production of sebum on the skin and its use in alopecia, with considerable practical advantages and with respect to the safety profile. | 02-11-2010 |
Sergio Baroni, Villa D'Adda(bg) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110152225 | PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants - Rosiglitazone, 5-ASA or structurally analogous Compounds according to the general formula (I): or Compounds according to the general formula (Ia): For the induction of CAMP expression in tissues having PPAR-gamma receptors. Such tissues include epithelia or mucosae tissue having PPAR-gamma receptors and of particular interest is CAMP expression in the gut. | 06-23-2011 |
Simona Baroni, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20100000564 | HAIR DYE COMPOSITION - A hair dye composition including a first part containing an alkaline agent and a second part containing an oxidizing agent, which are mixed together immediately before use, wherein at least one of the first part and the second part contains a diazacycloheptane represented by the following general formula (1) or a salt thereof, and the pH of the mixture is 7.5 to 12; | 01-07-2010 |